Co-morbidity

Clinical trials for Co-morbidity explained in plain language.

Never miss a new study

Get alerted when new Co-morbidity trials appear

Sign up with your email to follow new studies for Co-morbidity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Gentler myeloma treatment shows promise for frail patients

Disease control Ongoing

This study tests a combination of three drugs—isatuximab, pomalidomide, and dexamethasone—at lower doses than usual. It includes 6 patients with multiple myeloma that has returned or not responded to treatment, who are also vulnerable due to age or other health problems. The goal…

Matched conditions: CO-MORBIDITY

Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

Co-morbidity

Get alerted when new Co-morbidity trials appear

Gentler myeloma treatment shows promise for frail patients